These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 11521100
21. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Osugi H, Takemura M, Takada N, Hirohashi K, Kinoshita H, Higashino M. Br J Surg; 2002 Jul; 89(7):909-13. PubMed ID: 12081742 [Abstract] [Full Text] [Related]
22. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas. Liu P, Chen W, Zhu H, Liu B, Song S, Shen W, Wang F, Tucker S, Zhong B, Wang D. Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590 [Abstract] [Full Text] [Related]
23. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576 [Abstract] [Full Text] [Related]
25. Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection. Voltolini L, Rapicetta C, Luzzi L, Ghiribelli C, Ligabue T, Paladini P, Gotti G. Lung Cancer; 2006 Jun 01; 52(3):359-64. PubMed ID: 16644062 [Abstract] [Full Text] [Related]
26. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP. Ann Thorac Surg; 2008 Jun 01; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797 [Abstract] [Full Text] [Related]
27. Surgical treatment for locally advanced (T4) squamous cell carcinoma of the thoracic esophagus. Tachibana M, Dhar DK, Kinugasa S, Yoshimura H, Shibakita M, Ohno S, Ueda S, Fujii T, Kohno H, Nagasue N. Dysphagia; 2002 Jun 01; 17(4):255-61. PubMed ID: 12355140 [Abstract] [Full Text] [Related]
28. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Igaki H, Kato H, Tachimori Y, Nakanishi Y. Surgery; 2003 Apr 01; 133(4):368-74. PubMed ID: 12717353 [Abstract] [Full Text] [Related]
29. Prognostic variables in thoracic esophageal squamous cell carcinoma. Lin CS, Chang SC, Wei YH, Chou TY, Wu YC, Lin HC, Wang LS, Hsu WH. Ann Thorac Surg; 2009 Apr 01; 87(4):1056-65. PubMed ID: 19324127 [Abstract] [Full Text] [Related]
30. Rim versus sagittal mandibulectomy for the treatment of squamous cell carcinoma: two types of mandibular preservation. Guerra MF, Campo FJ, Gías LN, Pérez JS. Head Neck; 2003 Dec 01; 25(12):982-9. PubMed ID: 14648856 [Abstract] [Full Text] [Related]
31. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma. Zhao Y, Jiang Y, Wang R, Zheng X, Wang X, Jin B, Lu Y, Qiao T, Hong L, Fan D. Ann Surg Oncol; 2007 Sep 01; 14(9):2621-7. PubMed ID: 17570016 [Abstract] [Full Text] [Related]
32. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Aoki T, Sugaya M, Miyazawa Y, Hayashi H, Miyazaki S, Ochiai T. J Surg Oncol; 2003 Aug 01; 83(4):248-52. PubMed ID: 12884238 [Abstract] [Full Text] [Related]
33. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice]. Farzad M, De Luca MC, Rubino G, Pirtoli L, Pepi F, Sebaste L, Ponticelli P, Atzeni G, Maranzano E, Silvano G. Radiol Med; 2001 Aug 01; 102(1-2):72-7. PubMed ID: 11677442 [Abstract] [Full Text] [Related]
34. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer. Dhar DK, Hattori S, Tonomoto Y, Shimoda T, Kato H, Tachibana M, Matsuura K, Mitsumoto Y, Little AG, Nagasue N. Ann Thorac Surg; 2007 Apr 01; 83(4):1265-72. PubMed ID: 17383324 [Abstract] [Full Text] [Related]
35. Possible indication for surgical treatment of squamous cell carcinomas of the esophagus that involve the stomach. Doki Y, Ishikawa O, Kabuto T, Hiratsuka M, Sasaki Y, Ohigashi H, Kameyama M, Murata K, Yamada T, Miyashiro I, Yokoyama S, Imaoka S. Surgery; 2003 May 01; 133(5):479-85. PubMed ID: 12773975 [Abstract] [Full Text] [Related]
36. Correlation of pre-operative coexistence of organ dysfunction with overall survival of patients with squamous cell carcinoma of the thoracic esophagus. Nozoe T, Ezaki T, Takahashi I, Baba H, Maehara Y. Oncol Rep; 2004 Sep 01; 12(3):655-8. PubMed ID: 15289851 [Abstract] [Full Text] [Related]
37. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma]. Li XM, DI B, Shang YD, Li J, Cheng JM. Ai Zheng; 2005 Feb 01; 24(2):208-12. PubMed ID: 15694035 [Abstract] [Full Text] [Related]
38. [Analysis of prognostic factors in patients with carcinoma of the thoracic esophagus]. Suzuki H, Abo S, Kitamura M, Hashimoto M, Izumi K, Nakahori M. Nihon Kyobu Geka Gakkai Zasshi; 1991 Apr 01; 39(4):419-23. PubMed ID: 2051105 [Abstract] [Full Text] [Related]
39. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Ann Thorac Surg; 2004 Oct 01; 78(4):1177-83. PubMed ID: 15464466 [Abstract] [Full Text] [Related]
40. Surgical outcome after the clearance of abdominal metastatic lymph nodes in 138 patients with thoracic esophageal carcinoma. Shimada H, Okazumi S, Matsubara H, Shiratori T, Shuto K, Akutsu Y, Nabeya Y, Hayashi H, Ochiai T. Am J Surg; 2007 Apr 01; 193(4):448-52; discussion 453. PubMed ID: 17368286 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]